23m
Hosted on MSNBig relief for PF account holders, EPFO has again extended the last date for UAN activation for the ELI scheme, know what is the new deadline?Relief news has come for lakhs of members of EPF. The Employees' Provident Fund Organization (EPFO) has extended the last ...
35m
Hosted on MSNEli Manning posts the most embarrassing photo of himThe most embarrassing photo that exists of Eli Manning has officially gone viral, and we can thank the former New York Giants ...
The Other Guys is an action-comedy directed by Adam McKay, starring Will Ferrell and Mark Wahlberg as two mismatched NYPD ...
Eli Lilly (NYSE: LLY) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive ...
Hims & Hers stock tumbled after the company confirmed it would stop selling some compounded weight-loss drugs.
Eli Lilly and Company is unveiling its new 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, which will be available ...
With back to back seasons with wins in the double digits, the Missouri Tigers' brand continues to grow at a national level. In 2024, six players ...
The Burton Panthers made quick work of Luling last (Monday) night with a 14-1 victory in a game that was called after just ...
Wrestling reporter Eli McKown is putting together a mailbag to answer your questions about the upcoming postseason college ...
The payments company is building on a flurry of innovations unveiled in early 2024. A buy-the-dip approach is bolstering the chip maker as individual investors position for its shares to rally.
Eli Lilly is unleashing new ammunition in its fight against cheaper, compounded versions of its obesity blockbuster Zepbound.
Eli Lilly has reduced the price of its weight-loss drug, Zepbound, to combat competition from compounding pharmacies and Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results